Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents

被引:36
作者
Gradelski, E [1 ]
Kolek, B [1 ]
Bonner, DP [1 ]
Valera, L [1 ]
Minassian, B [1 ]
Fung-Tomc, J [1 ]
机构
[1] Bristol Myers Squibb Co, Dept Microbiol, Wallingford, CT 06457 USA
关键词
antimicrobial agents; FIC; time-kill analysis;
D O I
10.1016/S0924-8579(00)00317-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The influence of non-quinolone antimicrobial agents on the antibacterial activities of gatifloxacin and ciprofloxacin was determined using chequerboard. fractional inhibitory concentration, (FIC) and time-kill analysis methods. In the chequerboard method, the quinolones were tested in combination with ten antimicrobial agents (macrolides, aminoglycosides, p-lactams, vancomycin, rifampicin and chloramphenicol) against five bacterial strains (one strain each of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Enterococcus faecalis and Streptococcus pneumoniae). In no incidence was antagonism (FIC greater than or equal to 4) or synergy (FIC less than or equal to 0.5) observed; all dual drug combinations involving gatifloxaoin or ciprofloxacin showed additivity/indifference (FIC > 0.5, < 4). By time-kill analysis, the strains were tested at a quinolone concentration equal to 8 x MIC in combination with a second antibiotic at 0.5 x its MIG. These combinations killed non-enterococcal strains at rates similar to those with quinolones alone, However, rifampicin and chloramphenicol were often antagonistic (100-fold lesser killing) to the lethal action of gatifloxacin and ciprofloxacin against E. faecalis These findings indicate that, with the exception of E. faecalis, the antibacterial activities of quinolones are generally additive/indifferent to those of other antimicrobial agents. (C) 2001 Published by Elsevier Science B.V. and international Society of Chemotherapy. All rights reserved.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 7 条
[1]  
Eliopolous GM., 1996, Antibiotics in laboratory medicine, P330
[2]   Comparative killing rates of fluoroquinolones and cell wall-active agents [J].
Fung-Tomc, JC ;
Gradelski, E ;
Valera, L ;
Kolek, B ;
Bonner, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) :1377-1380
[3]   THE MODE OF ACTION OF QUINOLONES - THE PARADOX IN ACTIVITY OF LOW AND HIGH-CONCENTRATIONS AND ACTIVITY IN THE ANAEROBIC ENVIRONMENT [J].
LEWIN, CS ;
MORRISSEY, I ;
SMITH, JT .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (04) :240-248
[4]  
MAGGIOLO F, 1998, 38 ISAAC
[5]  
*NAT COMM CLIN LAB, 1997, M7A4 NAT COMM CLIN L
[6]  
NEU HC, 1989, REV INFECT DIS, V11, pS1025
[7]   In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci [J].
Schick, DG ;
Canawati, HN ;
Montgomerie, JZ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (04) :233-239